Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Tokyo VD who wrote (5888)	10/16/1998 10:32:00 AM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

Tokyo-- I was thinking that maybe that is why ZONA is off this morning. CNBC mentioned a staggering diminution in sales on Viagra, and MUSE. VVUS is practically out of biz to read the earnings report. Scary. All the people on that thread, after Viagra was released, were SURE that Viagra would ultimately increase Muse's sales. Well, not only didn't Viagra increase Muse's sales, it pretty much as put them out of business, and worse, even Viagra's sales aren't anything like what they were, or what was expected. So the market is much less than was thought, after the initial excitement. It bodes very poorly for Vasomax IMO and I think other CNBC viewers may have concluded similarly. CNBC gave the figures, talked about how the market had been overestimated. --Linda